BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$72.32
-0.30%
Mkt Cap $14.66B
Analyst Ratings
Buy
22
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
Implied Upside
+44.6%
Consensus $104.60 vs current $72.32
NASDAQ·Healthcare·Biotechnology
$72.32
-0.30%
Mkt Cap $14.66B
Buy
22
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
+44.6%
Consensus $104.60 vs current $72.32